A report from the United Nations (UN) agency focused on ending the AIDS epidemic said there's a clear path to end the epidemic by 2030, in today's bite-sized hospital and health industry news from the District of Columbia, Michigan, and New York.

• District of Columbia: FDA on Monday approved the first vaccine for respiratory syncytial virus (RSV) in children ages 1 and younger. The monoclonal antibody vaccine, Beyfortus, which is developed by Sanofi and AstraZeneca, is expected to be available at the beginning of the fall RSV season. RSV is considered the second leading cause of death during the first year of a child's life, and around 80,000 children ages 5 and younger are hospitalized with the virus every year, according to CDC. (Gonzalez, Axios, 7/17; Jewett, New York Times, 7/17)
• Michigan: Physicians, nurses, and other ED workers contracted through TeamHealth working at Ascension St. John Hospital in Detroit have voted 31-0 to unionize. The union, called the Greater Detroit Association of Emergency Physicians, includes full-time and regular part-time physicians, lead advanced practice clinicians, physician assistants, and nurse practitioners. A spokesperson for TeamHealth said its "focus remains working with our hospital partners on serving patients and supporting our frontline clinicians" and that the company is "committed to working with the union and bargaining in good faith on those issues that are within our control while continuing to focus on protecting access to care for the community." (Henderson, MedPage Today, 7/17)
• New York: A report from the UN agency focused on ending the AIDS epidemic said there's a clear path to end the epidemic by 2030, and that ending the AIDS epidemic is a political and financial choice. According to Winnie Byanyima, executive director of UNAIDS, the report breaks down how countries "that put people and communities first in their policies and programs are already leading the world on the journey to end AIDS by 2030." Byanyima specifically pointed to Botswana, Eswatini, Rwanda, the United Republic of Tanzania, and Zimbabwe, which have reached the "95-95-95" targets, meaning 95% of people living with HIV know their status, 95% of people with HIV are on antiretroviral treatment, and 95% of people on treatment are virally suppressed. "The data and real-world examples in the report make it very clear what that path is. It is not a mystery. It is a choice," Byanyima said. "Some leaders are already following the path — and succeeding." (Nazzaro, The Hill, 7/17)